Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
about
Epilepsy related to developmental tumors and malformations of cortical developmentHemostasis and alterations of the central nervous systemHomeostatic bioenergetic network regulation - a novel concept to avoid pharmacoresistance in epilepsy.Monocyte chemoattractant protein-1 affects migration of hippocampal neural progenitors following status epilepticus in rats.Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.Genomic analysis of the molecular neuropathology of tuberous sclerosis using a human stem cell model.The role of inflammation in epilepsyInflammation in epilepsy: clinical observations.Astrocyte immune responses in epilepsy.Tuberous sclerosis and epilepsy: role of astrocytes.Immunity and Inflammation in Epilepsy.A potential role for glia-derived extracellular matrix remodeling in postinjury epilepsy.Focal epilepsy associated with glioneuronal tumors.Cortical myoclonus during IV thrombolysis for ischemic stroke.Cell injury and premature neurodegeneration in focal malformations of cortical development.Acute seizures in acute ischemic stroke: does thrombolysis have a role to play?Epileptic manifestations in stroke patients treated with intravenous alteplase.Urokinase-type plasminogen activator receptor modulates epileptogenesis in mouse model of temporal lobe epilepsy.
P2860
Q26829946-42638FEE-4DDE-45C7-99D6-5544719DCF7DQ33842161-8C7E269C-37FD-4944-A36F-F1D18D55D628Q35072901-596819A1-B1D6-461B-B1A2-D2A4AB765AA5Q36585380-BEAFA3BA-B9F6-4450-A58B-7BF0DD727668Q36815367-4D2E36A9-1FDA-4414-B31E-81F213B407B9Q37272605-FAFB2A5A-B63A-468C-9E40-9ED8E588188DQ37816957-1CA1E56E-44F5-4087-B854-C3D3354CCEDCQ37872029-CBF6B62B-9CF7-47E6-BFD4-C9BA1146CEB0Q37983788-CB2DF03A-A70E-4E65-BA13-CB9BF944AF1BQ37995965-D7C56032-4CA4-4543-A855-BAF3336C7FABQ38673807-5596D6FB-290E-4BFC-ACB2-10E8CBA3143CQ38856077-5481F6AA-C730-4B82-ABDF-D499342FFBB4Q40579773-08CDF982-31F1-49B2-9EDD-D2FD751DBD34Q41776019-867F3423-BC40-49E3-B60E-2ED793A15551Q45213406-FD65EDF2-5544-4A2E-9E66-48E84AF70D60Q46967338-1B5B4350-F639-4542-87BE-D2EA16F08BBFQ47392443-503BDC7A-10D0-4D5A-AED0-5C6210F67E45Q48242715-E21AAD16-EFB4-41C2-A23E-4E6653A343F1
P2860
Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tissue plasminogen activator a ...... man epileptogenic pathologies.
@ast
Tissue plasminogen activator a ...... man epileptogenic pathologies.
@en
Tissue plasminogen activator a ...... man epileptogenic pathologies.
@nl
type
label
Tissue plasminogen activator a ...... man epileptogenic pathologies.
@ast
Tissue plasminogen activator a ...... man epileptogenic pathologies.
@en
Tissue plasminogen activator a ...... man epileptogenic pathologies.
@nl
prefLabel
Tissue plasminogen activator a ...... man epileptogenic pathologies.
@ast
Tissue plasminogen activator a ...... man epileptogenic pathologies.
@en
Tissue plasminogen activator a ...... man epileptogenic pathologies.
@nl
P2093
P50
P1433
P1476
Tissue plasminogen activator a ...... uman epileptogenic pathologies
@en
P2093
G C Di Gennaro
J A Gorter
J C Baayen
P C van Rijen
W G M Spliet
P304
P356
10.1016/J.NEUROSCIENCE.2010.02.047
P407
P577
2010-02-26T00:00:00Z